Progressive osseous heteroplasia: A case report with an unexpected trigger
Alessandra Boncompagni,
Angela K. Lucas-Herald,
Paula Beattie,
Helen McDevitt,
Lorenzo Iughetti,
Panayiotis Constantinou,
Esther Kinning,
S. Faisal Ahmed,
Avril Mason
Affiliations
Alessandra Boncompagni
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, United Kingdom; Postgraduate School of Paediatrics, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena & Reggio Emilia, Paediatric Unit, Modena, Italy
Angela K. Lucas-Herald
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, United Kingdom
Paula Beattie
Department of Paediatric Dermatology, Royal Hospital for Children, Glasgow, United Kingdom
Helen McDevitt
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, United Kingdom
Lorenzo Iughetti
Postgraduate School of Paediatrics, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena & Reggio Emilia, Paediatric Unit, Modena, Italy
Panayiotis Constantinou
Department of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, United Kingdom
Esther Kinning
Department of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, United Kingdom; Department of Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom
S. Faisal Ahmed
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, United Kingdom
Avril Mason
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, United Kingdom; Corresponding author at: Department of Paediatric Endocrinology, School of Medicine, Dentistry & Nursing, University of Glasgow, Office Block, Royal Hospital for Children, Glasgow G51 4TF, United Kingdom.
Progressive osseous heteroplasia (POH) is a rare genetic disorder characterised by progressive heterotopic ossification (HO) within the skin and subcutaneous tissues. The condition is caused by heterozygous inactivating mutations of the GNAS gene and usually presents in infancy. We describe the case of a white male ex-preterm who was first referred because of subcutaneous calcium deposits along the right arm after extravasation of parenteral nutrition. As these lesions progressed, a skin biopsy was undertaken which revealed intramembranous ossification. Genetic testing revealed a constitutional, de novo, heterozygous, nonsense variant in the GNAS gene that has not previously been described, but which is consistent with patient's clinical diagnosis of POH. No endocrine abnormalities or other signs congruent with overlapping conditions were detected. To the best of our knowledge, this is the first case describing an inflammatory trigger in POH. Trials with intravenous bisphosphonate and glucocorticoid as well as with topical sodium thiosulphate were attempted without clinical improvement. Excision of the calcifications and physiotherapy seem to have provided a partial improvement on mobility of the elbow. This case widens the spectrum of phenotypes seen in GNAS mutation disorders and suggests that alternative anti-inflammatory treatments may be effective. Mutations in GNAS should be considered in cases of significant progressive calcium deposition after extravasation injury.